Patent 7737113 was granted and assigned to Zealand Pharma A/S on June, 2010 by the United States Patent and Trademark Office.
Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.